Rectal Cancer Clinical Trials in Guangzhou, Guangdong
16 recruitingGuangzhou, Guangdong, China
Showing 1–16 of 16 trials
Recruiting
Phase 3
Neoadjuvant mFOLFOXIRI Plus Bevacizumab in Patients With High-Risk Locally Advanced Rectal Cancer
Rectal Cancer
Yanhong Deng582 enrolled1 locationNCT04215731
Recruiting
A Study on the Accurate Evaluation of Pseudoprogression of Rectal Cancer Immunotherapy Based on Multitemporal and Multiparameter MRI
Rectal Cancer
Peiyi Xie300 enrolled2 locationsNCT07381322
Recruiting
Application of Amide Proton Transfer-Weighted Imaging in Predicting Pathological Complete Response After Neoadjuvant Therapy of Rectal Cancer
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University320 enrolled2 locationsNCT06719414
Recruiting
Not Applicable
Watch and Wait in PD-1 Monoclonal Antibody Treated dMMR/MSI-H Distal Rectal Cancer
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University47 enrolled1 locationNCT04643041
Recruiting
Phase 2Phase 3
Node-Sparing Short-Course Radiotherapy Sequential Chemotherapy and PD-1 Inhibitor for Mid/Low pMMR/MSS Rectal Cancer (MODIFI-RC-II)
Rectal CancerRadiotherapyNeoadjuvant Therapies+1 more
Sixth Affiliated Hospital, Sun Yat-sen University430 enrolled1 locationNCT06958432
Recruiting
Predicting the Efficacy of Neoadjuvant Therapy in Patients With Locally Advanced Rectal Cancer Using an AI Platform Based on Multi-parametric MRI
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University1,700 enrolled4 locationsNCT05523245
Recruiting
Phase 2
Treating Locally Advanced Rectal Cancer With TAS-102 Chemotherapy Plus Neoadjuvant Radiotherapy
Rectal Cancer
Sun Yat-sen University65 enrolled1 locationNCT05965531
Recruiting
Phase 2
Modified Long-Course Radiotherapy Followed by Chemotherapy and PD-1 Inhibitor for MSS/pMMR High-risk Mid/Low LARC (MODIFI-RC-I)
Rectal CancerRadiotherapyNeoadjuvant Therapies+1 more
Sixth Affiliated Hospital, Sun Yat-sen University80 enrolled1 locationNCT06923345
Recruiting
Flexible Colonoscope Assisted Hybrid Transanal Total Mesorectal Resection (taTME)
Rectal Cancer
Sun Yat-sen University5 enrolled1 locationNCT06380855
Recruiting
Not Applicable
Proximally Extended Resection for Rectal Cancer After Neoadjuvant Chemoradiotherapy
Rectal Cancer
Sixth Affiliated Hospital, Sun Yat-sen University240 enrolled1 locationNCT02649647
Recruiting
Phase 2
Neoadjuvant Chemoradiotherapy Plus Sintilimab for Intermediate/High Immunoscore Locally Advanced Rectal Cancer
Rectal Cancer
Yanhong Deng51 enrolled1 locationNCT05450029
Recruiting
Not Applicable
Salvage Chemotherapy Versus Total Mesorectal Resection for Local Resection Rectal Cancer Patients
Rectal CancerChemotherapy Effect
Sun Yat-sen University392 enrolled1 locationNCT06043999
Recruiting
Phase 3
The Efficacy of Primary Total Mesorectal Excision (TME) Surgery Versus Neoadjuvant Chemotherapy Combined With TME Surgery in Low-risk Locally Advanced Rectal Cancer
Rectal Cancer
Sun Yat-sen University766 enrolled6 locationsNCT05984485
Recruiting
Not Applicable
Toripalimab Combined With Neoadjuvant Chemoradiotherapy as First-line Treatment for Locally Advanced，High-Risk，MSS Rectal Cancer
Rectal CancerLocally AdvancedMSS+1 more
Nanfang Hospital, Southern Medical University53 enrolled1 locationNCT05877573
Recruiting
Not Applicable
Targeted Optical Biopsy for Local Rectal Scars in Rectal Cancer Patients After Neoadjuvant Chemoradiotherapy
Rectal Cancer
Nanfang Hospital, Southern Medical University68 enrolled1 locationNCT05316103
Recruiting
Phase 3
Prospectively Randomized Control Clinical Trial of FOLFOXIRI Preoperative Chemotherapy Alone on Rectal Cancer in Local Advance Comparing to Oral Capecitabine Combined With Long-term Radiation
Rectal Cancer
Sun Yat-sen University776 enrolled2 locationsNCT03671252